Share this article
Share this article
MINNEAPOLIS, Feb. 2, 2021 /PRNewswire/ Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020.
Second Quarter FY2021 Snapshot
Second quarter organic revenue increased by 19% (21% reported) to $224.3 million and 15% (16% reported) in the first half of fiscal 2021 to $428.5 million.
GAAP EPS was $1.15 versus $3.02 one year ago primarily relating to a non-recurring gain of approximately $121 million in our ChemoCentryx investment in the second quarter of fiscal 2020. Delivered record adjusted earnings per share (EPS) of $1.62 versus $1.08 one year ago.
Adjusted Operating Margin increased to 38.7% in the second quarter of fiscal 2021 compared to 33.4% in the second quarter of fiscal 2020.
Operator
Good morning, and welcome to the Bio-Techne earnings conference call for the Second Quarter of Fiscal Year 2021. [Operator Instructions]
I would now like to turn the call over to David Clair, Bio-Techne s Senior Director, Investor Relations and Corporate Development.
David Clair
Senior Director, Investor Relations & Corporate Development
Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Chief Executive Officer; and Jim Hippel, Chief Financial Officer of Bio-Techne. Before we begin, let me briefly cover our safe harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company s future results as well as the potential impact of the COVID-19 pandemic on our operations and financial results.
Meriden-based Protein Sciencesâ parent company to make Pfizer vaccine
Meriden-based Protein Sciencesâ parent company to make Pfizer vaccine
Clem Lewin, associate vice president of research and development strategy at Sanofi, speaks to the media as Lt. Gov. Susan Bysiewicz, left, Connecticut Gov. Ned Lamont, second from right, and Mireli Fino, site head at Protein Sciences, listen during visit by the governor to Protein Sciences, Thursday, March 12, 2020, in Meriden. (AP Photo/Jessica Hill)
January 27, 2021 06:14PM By Mary Ellen Godin, Record-Journal staff
Sanofi Pasteur, parent company of Meriden-based Protein Sciences, has agreed to manufacture the Pfizer BioNTech vaccine after clinical trials of its own vaccine were delayed in December, the company announced this week.
Weekly allotment of COVID vaccine is set to increase from 46,000 to about 54,000 doses Author: Matt Caron Updated: 4:36 PM EST January 27, 2021
MERIDEN, Conn. The Biden administration will order 200-million more doses of the COVID vaccines from Pfizer and Moderna. It s in an effort to reach their goal of 100-million doses in 100 days. But those doses won’t just magically appear.
At Protein Sciences in Meriden, they’ve been developing two of their own COVID vaccines, but last month, they hit a snag. The concentration of their formula wasn t strong enough to produce an adequate immune response in older adults. So now, they are shifting focus to help Pfizer manufacture their vaccine while also continuing their own research.
Her appointment came one year after acting in that capacity between January and December 2020.
According to the university’s spokesman, Oluwadare Adebisi, the appointment was confirmed by the institution’s Board of Trustees.
According to Adebisi, Kuku’s leadership qualities, enthusiasm, and passion for excellence were on “full display” over the past 12 months that she acted in the position before the recent confirmation.
“Since she assumed office, she has designed and implemented pragmatic blueprints to place Kings University in an enviable position in the comity of Universities. Amongst her numerous achievements is the deployment of the Kings University Learning Management System (KULMS) during the COVID-19 pandemic. This virtual platform served as a medium of robust academic engagements for staff and students, thus, ensuring that teaching and learning are not interrupted despite the physical closure of the academic institutions,” a statement by the institution said